Interestingly, IFNAR and IFN-γ deficiency have been shown to protect against hepatic inflammation in other disease contexts, such as experimental severe malaria, and PBMCs of patients with malaria also exhibit a high type I IFN signature.29 This evidence concerns the gene IFNAR1 and malaria.